<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Surgical resection for colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> (CRHM) is the preferred treatment for suitable candidates, and the only potentially curative modality </plain></SENT>
<SENT sid="1" pm="."><plain>However, due to various limitations, the majority of patients with CRHM are not candidates for liver resection </plain></SENT>
<SENT sid="2" pm="."><plain>In recent years, there has been an increasing interest in the role of thermal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> ablation (TTA) as a component of combined resection-ablation strategies, staged hepatic resections, or as standalone adjunct treatment for patients with CRHM </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, ablative approaches have expanded the group of patients with CRHM that may benefit from liver-directed treatment strategies </plain></SENT>
</text></document>